The global anatomic pathology market is divided geographically into North America, Europe, the Asia Pacific, and the others. In 2019, the largest market share was represented by North America, followed by Europe. The growth of the anatomical pathology market in North America is driven by factors like the growing prevalence of chronic diseases, growing health expenditure, high-quality infrastructures for hospitals and clinical laboratories, as well as the presence of key players in the regions.
In November 2018, one of the key players, Quest Diagnostics Incorporated (NYSE: DGX), announced the acquisition of the assets of the Boyce and the Bynum Pathology Laboratories (BBPL), a leading diagnosis and clinical laboratory services provider in the Midwest. The BBPL / Quest partnership would result in a broader range of clinical laboratory and anatomical pathology facilities across the United States. In addition, the partnership would provide patients with more convenient access to an expanded network of service centres throughout the Midwest. This has aided the growth of the global anatomic pathology market and is likely to continue favouring the market development in the forecast period as well.
The technological advancements and innovations in the industry are also aiding the global anatomic pathology market growth. In September 2018, Sakura Finetek, another key player, unveiled the manual microtome Accu-Cut SRM 300 LT, an integrated4-color LED rear illumination 3D precision chuck, a new feature which allows for the more simplified observation of paraffin-embedded tissue samples for the rapid display of translucent biopsies.
Market Analysis by Product and Service, Application, End Use, and Regions:
Key Findings of the Report:
Key Offerings of the Report:
The major key players in the global anatomic pathology market include companies like Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Ventana Medical Systems, Inc, Cardinal Health, Agilent Technologies, Inc., Sakura Finetek USA, Inc., and NeoGenomics Laboratories, Inc., among others. The comprehensive report covers their market share, capacity, and latest developments like mergers and acquisitions, and capacity expansions.
EMR is a leading business intelligence company, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At EMR, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.